Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. | Chief Business Officer | Restricted Stock Units | 40K | $631K | $15.78 | Mar 27, 2024 | Direct |
Stoke Therapeutics, Inc. | Chief Business Officer | Common Stock | 0 | $0 | $13.90 | Jul 2, 2024 | Direct |
Stoke Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 46K | May 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | Jul 2, 2024 | 2 | -$32.8K | 4 | Jul 3, 2024 | Chief Business Officer |
STOK | Stoke Therapeutics, Inc. | May 20, 2024 | 3 | -$750K | 4 | May 22, 2024 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Apr 1, 2024 | 4 | -$791K | 4 | Apr 3, 2024 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Mar 27, 2024 | 2 | $0 | 4 | Jun 7, 2024 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2024 | 3 | -$25.1K | 4 | Mar 19, 2024 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Dec 1, 2023 | 2 | $0 | 4 | Dec 5, 2023 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2022 | 1 | $0 | 4 | Mar 17, 2022 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Jan 3, 2022 | 5 | -$79.3K | 4 | Jan 5, 2022 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Dec 1, 2021 | 4 | -$127K | 4 | Dec 3, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Nov 1, 2021 | 7 | -$124K | 4 | Nov 3, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Oct 1, 2021 | 3 | -$129K | 4 | Oct 4, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Sep 1, 2021 | 3 | -$136K | 4 | Sep 2, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Aug 2, 2021 | 3 | -$152K | 4 | Aug 4, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Jul 1, 2021 | 3 | -$178K | 4 | Jul 2, 2021 | COO & CBO |
STOK | Stoke Therapeutics, Inc. | Jun 1, 2021 | 3 | -$21.4K | 4 | Jun 3, 2021 | COO & CBO |